While acute nausea and vomiting typically resolve, some patients experience persistent mild gastrointestinal changes including constipation, loose stools, or reduced appetite even after one year of use
Mounjaro is licensed for both type 2 diabetes and weight management
One important exception: if the food noise only shows up in the day or two before your next injection, thats a normal part of the weekly medication cycle not a sign your dose has stopped working
Additionally, some users metabolize brand-name Mounjaro differently than compounded formulations due to excipients, pH buffering, or stabilizer differences that affect bioavailability and sustained release
Even less is known about how these reasons differ between those using GLP-1 RAs as anti-obesity medications (AOMs) versus those using them for antidiabetic management (ADMs), or how these patterns have changed over time as awareness, access, and prescribing practices have evolved
